OrthoPediatrics Corp. Files 8-K on Shareholder Vote

Ticker: KIDS · Form: 8-K · Filed: May 28, 2024 · CIK: 1425450

Orthopediatrics Corp 8-K Filing Summary
FieldDetail
CompanyOrthopediatrics Corp (KIDS)
Form Type8-K
Filed DateMay 28, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.00025
Sentimentneutral

Sentiment: neutral

Topics: shareholder-vote, corporate-governance

Related Tickers: KIDS

TL;DR

OrthoPediatrics (KIDS) filed an 8-K for a shareholder vote on 5/24.

AI Summary

OrthoPediatrics Corp. filed an 8-K on May 28, 2024, reporting on a matter submitted to a vote of security holders on May 24, 2024. The filing pertains to the company's common stock, traded under the ticker KIDS on the Nasdaq Global Market.

Why It Matters

This filing indicates a formal process where shareholders are being asked to vote on a specific matter, which could impact corporate governance or strategic decisions.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote, not an indication of immediate financial distress or significant operational change.

Key Players & Entities

  • ORTHOPEDIATRICS CORP (company) — Registrant
  • KIDS (company) — Trading Symbol
  • Nasdaq Global Market (company) — Exchange
  • May 24, 2024 (date) — Date of earliest event reported
  • May 28, 2024 (date) — Date of Report

FAQ

What specific matter was submitted for a vote of security holders?

The filing does not specify the exact matter submitted for a vote, only that it occurred on May 24, 2024.

When was this 8-K filing submitted?

The 8-K filing was submitted on May 28, 2024.

What is the trading symbol for OrthoPediatrics Corp. common stock?

The trading symbol for OrthoPediatrics Corp. common stock is KIDS.

On which exchange is OrthoPediatrics Corp. common stock traded?

OrthoPediatrics Corp. common stock is traded on the Nasdaq Global Market.

What is the principal executive office address for OrthoPediatrics Corp.?

The principal executive offices are located at 2850 Frontier Drive, Warsaw, Indiana 46582.

Filing Stats: 619 words · 2 min read · ~2 pages · Grade level 12.9 · Accepted 2024-05-28 11:34:42

Key Financial Figures

  • $0.00025 — ange on which registered Common Stock, $0.00025 par value per share KIDS Nasdaq Global

Filing Documents

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. On May 24, 2024, OrthoPediatrics Corp. (the "Company") held its 2024 Annual Meeting of Stockholders and the Company's stockholders voted on the following matters: Election of Directors The nominees below were elected to serve as directors for a term that will last until the Company's 2027 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows: Name Votes For Votes Withheld Broker Non-Votes David R. Bailey 18,199,037 1,790,600 727,703 Marie C. Infante 12,686,531 7,186,996 843,813 Jimmy D. McDonald 14,265,857 5,721,728 729,755 Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows: For Against Abstain Broker Non-Votes 19,430,742 258,906 304,480 723,212 Approval of the OrthoPediatrics Corp. 2024 Incentive Award Plan The Company's stockholders approved the OrthoPediatrics Corp. 2024 Incentive Award Plan by voting as follows: For Against Abstain Broker Non-Votes 18,409,907 1,279,054 305,167 723,212 Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2024 The Company's stockholders approved the appointment by the Audit Committee of the Company's Board of Directors of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 by voting as follows: For Against Abstain 20,565,406 150,366 1,568 * * * * * * SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the und

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.